Leukine
NDC 71837-5843, SARGRAMOSTIM, injection, powder, lyophilized, for solution, from Partner Therapeutics, Inc..
- Product NDC
- 71837-5843
- Status
- Listed
- Labeler
- Partner Therapeutics, Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA103362
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71837-5843 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SARGRAMOSTIM250 ug/mL
Pharmacologic classes
Granulocyte Colony-Stimulating Factor [CS]; Granulocyte-Macrophage Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71837-5843-5 | 71837584305 | 5 VIAL, SINGLE-DOSE in 1 CARTON (71837-5843-5) / 1 mL in 1 VIAL, SINGLE-DOSE (71837-5843-1) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/bb9a3820-f31a-4dd9-bef4-97094c01a398Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=71837-5843
Use it
Look up 71837-5843 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71837-5843 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71837-5843. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.